pharmadog
fetch the data · sniff the signal
© 2026 pharmadog.xyz
made by humans and a good dog
🐶
Opzelura · pharmadog
pharmadog › drugs › Opzelura
Opzelura Marketed updated 2mo ago by $INCY INCYTE CORP 🔗 ChEMBL Approved
community read 0 votes
↑ 0 good boy ↓ 0 doghouse
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 6 investigational indications.
targets Tyrosine-protein kinase JAK1 Tyrosine-protein kinase JAK2
all catalysts(0) nothing on the calendar yet
News(0) no news has mentioned this drug yet
trade names
Jakafi, Jakavi, Opzelura
generic
ruxolitinib phosphate
MOA
Tyrosine-protein kinase JAK1 inhibitor; Tyrosine-protein kinase JAK2 inhibitor
indication
Hidradenitis Suppurativa
Data sources
last refreshed 1h ago
Found something off? report 🐶 something off?
Report a data issue Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.
cancel send
Patent cliff source: FDA Orange Book first barrier falls
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (112) May 5, 2041 method-of-use (U-3550) US 11602536 Sep 4, 2040 method-of-use (U-3505) US 11510923 Sep 4, 2040 method-of-use (U-3505) US 11590137 Jul 28, 2040 method-of-use (U-4151) US 12233067 Jun 10, 2040 method-of-use (U-3551) US 11590138 Nov 20, 2031 patent US 10758543*PED Nov 20, 2031 patent US 10869870*PED Nov 20, 2031 patent US 11219624*PED May 20, 2031 formulation US 10758543 4.9y May 20, 2031 method-of-use (U-3229) US 10869870 4.9y May 20, 2031 formulation US 11219624 4.9y May 20, 2031 formulation US 11571425 4.9y May 20, 2031 method-of-use (U-3404) US 11590136 4.9y May 20, 2031 formulation US 12226419 4.9y May 20, 2031 formulation US 12544381 4.9y May 20, 2031 formulation US 12564593 4.9y Dec 12, 2028 patent US 10016429*PED 2.4y Dec 12, 2028 patent US 10016429*PED 2.4y Dec 12, 2028 patent US 10016429*PED 2.4y Dec 12, 2028 patent US 10016429*PED 2.4y Dec 12, 2028 patent US 10016429*PED 2.4y Dec 12, 2028 patent US 10610530*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8722693*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8822481*PED 2.4y Dec 12, 2028 patent US 8829013*PED 2.4y Dec 12, 2028 patent US 8829013*PED 2.4y Dec 12, 2028 patent US 8829013*PED 2.4y Dec 12, 2028 patent US 8829013*PED 2.4y Dec 12, 2028 patent US 8829013*PED 2.4y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 7598257*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 24, 2028 patent US 8415362*PED 2.0y Jun 12, 2028 method-of-use (U-3230) US 10016429 1.9y Jun 12, 2028 method-of-use (U-3230) US 10016429 1.9y Jun 12, 2028 method-of-use (U-3230) US 10016429 1.9y Jun 12, 2028 method-of-use (U-3230) US 10016429 1.9y Jun 12, 2028 method-of-use (U-3230) US 10016429 1.9y Jun 12, 2028 method-of-use (U-3229) US 10610530 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 composition US 8722693 1.9y Jun 12, 2028 method-of-use (U-3229) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3230) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3230) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3230) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3230) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3230) US 8822481 1.9y Jun 12, 2028 method-of-use (U-3228) US 8829013 1.9y Jun 12, 2028 method-of-use (U-3227) US 8829013 1.9y Jun 12, 2028 method-of-use (U-3227) US 8829013 1.9y Jun 12, 2028 method-of-use (U-3227) US 8829013 1.9y Jun 12, 2028 method-of-use (U-3228) US 8829013 1.9y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 7598257 1.5y Dec 24, 2027 composition US 8415362 1.5y Dec 24, 2027 composition US 8415362 1.5y Dec 24, 2027 composition US 8415362 1.5y Dec 24, 2027 composition US 8415362 1.5y Dec 24, 2027 composition US 8415362 1.5y Dec 24, 2027 composition US 8415362 1.5y Jun 12, 2027 patent US 10639310*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9079912*PED 340d Jun 12, 2027 patent US 9814722*PED 340d Jun 12, 2027 patent US 9814722*PED 340d Jun 12, 2027 patent US 9814722*PED 340d Jun 12, 2027 patent US 9814722*PED 340d Jun 12, 2027 patent US 9814722*PED 340d Jun 12, 2027 patent US 9974790*PED 340d Dec 12, 2026 method-of-use (U-3229) US 10639310 158d Dec 12, 2026 method-of-use (U-3230) US 9079912 158d Dec 12, 2026 method-of-use (U-3230) US 9079912 158d Dec 12, 2026 method-of-use (U-3230) US 9079912 158d Dec 12, 2026 method-of-use (U-3230) US 9079912 158d Dec 12, 2026 method-of-use (U-3230) US 9079912 158d Dec 12, 2026 method-of-use (U-3229) US 9079912 158d Dec 12, 2026 method-of-use (U-3230) US 9814722 158d Dec 12, 2026 method-of-use (U-3230) US 9814722 158d Dec 12, 2026 method-of-use (U-3230) US 9814722 158d Dec 12, 2026 method-of-use (U-3230) US 9814722 158d Dec 12, 2026 method-of-use (U-3230) US 9814722 158d Dec 12, 2026 method-of-use (U-3229) US 9974790 158d FDA exclusivities (33) Mar 22, 2029 PED Pediatric (6mo bonus) 2.7y Mar 22, 2029 PED Pediatric (6mo bonus) 2.7y Mar 22, 2029 PED Pediatric (6mo bonus) 2.7y Mar 22, 2029 PED Pediatric (6mo bonus) 2.7y Mar 22, 2029 PED Pediatric (6mo bonus) 2.7y Sep 22, 2028 ODE-373 Orphan Drug (7y) 2.2y
Sep 22, 2028 ODE-373 Orphan Drug (7y) 2.2y
Sep 22, 2028 ODE-373 Orphan Drug (7y) 2.2y
Sep 22, 2028 ODE-373 Orphan Drug (7y) 2.2y
Sep 22, 2028 ODE-373 Orphan Drug (7y) 2.2y
Sep 18, 2028 NPP New Product (3y) 2.2y
Nov 24, 2026 PED Pediatric (6mo bonus) 140d
Nov 24, 2026 PED Pediatric (6mo bonus) 140d
Nov 24, 2026 PED Pediatric (6mo bonus) 140d
Nov 24, 2026 PED Pediatric (6mo bonus) 140d
Nov 24, 2026 PED Pediatric (6mo bonus) 140d
Jun 19, 2026 PED Pediatric (6mo bonus)
Jun 19, 2026 PED Pediatric (6mo bonus)
Jun 19, 2026 PED Pediatric (6mo bonus)
Jun 19, 2026 PED Pediatric (6mo bonus)
Jun 19, 2026 PED Pediatric (6mo bonus)
May 24, 2026 ODE-238 Orphan Drug (7y)
May 24, 2026 ODE-238 Orphan Drug (7y)
May 24, 2026 ODE-238 Orphan Drug (7y)
May 24, 2026 ODE-238 Orphan Drug (7y)
May 24, 2026 ODE-238 Orphan Drug (7y)
Jan 18, 2026 PED Pediatric (6mo bonus)
Dec 19, 2025 M-285 Method (3y)
Dec 19, 2025 M-285 Method (3y)
Dec 19, 2025 M-285 Method (3y)
Dec 19, 2025 M-285 Method (3y)
Dec 19, 2025 M-285 Method (3y)
Jul 18, 2025 I-896 Indication (3y) 
comments(0)
5-min edit window · permanent after that